Table 3. Survival and other results of... | American Society of Hematology

Table 3.

Survival and other results of induction in priming randomization

	GM-CSF	Placebo	All
CR, %
All patients, n = 235	38	40	30
Younger than 70 y*	42	51	46
70 y or older	28	26	27
Therapy-related mortality in induction, %†	26	17	22
Overall survival, median mo†	5.3	8.5	6.7
Disease-free survival, median mo‡	6.9	5.1	6.1

	GM-CSF	Placebo	All
CR, %
All patients, n = 235	38	40	30
Younger than 70 y*	42	51	46
70 y or older	28	26	27
Therapy-related mortality in induction, %†	26	17	22
Overall survival, median mo†	5.3	8.5	6.7
Disease-free survival, median mo‡	6.9	5.1	6.1

P = .31 for GM-CSF versus placebo.

P = .11 for GM-CSF versus placebo.

There were 77 patients in CR; P = .73 for GM-CSF versus placebo.